dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Marín Sánchez, Ana María |
dc.contributor.author | Alvarez De la Sierra, Daniel |
dc.contributor.author | González López, Oscar |
dc.contributor.author | Lucas-Martin, Ana |
dc.contributor.author | Sellés Sanchez, Alicia |
dc.contributor.author | Rudilla Salvador, Francesc |
dc.contributor.author | Enrich Rande, Emma |
dc.contributor.author | Colobran Oriol, Roger |
dc.contributor.author | Pujol-Borrell, Ricardo |
dc.date.accessioned | 2020-02-24T13:24:57Z |
dc.date.available | 2020-02-24T13:24:57Z |
dc.date.issued | 2019-07-18 |
dc.identifier.citation | Marín-Sánchez A, Álvarez-Sierra D, González O, Lucas-Martin A, Sellés-Sánchez A, Rudilla F, et al. Regulation of TSHR expression in the thyroid and thymus may contribute to TSHR tolerance failure in Graves’ disease patients via two distinct mechanisms. Front Immunol . 2019 Jul 18;10:1695. |
dc.identifier.issn | 1664-3224 |
dc.identifier.uri | https://hdl.handle.net/11351/4675 |
dc.description | Malaltia de Graves; TSHR; Tolerància |
dc.description.sponsorship | This study was funded by Instituto de Salud Carlos III, grants PI14/00848, and PI17/00324, co-financed by the European Regional Development Fund (ERDF). DÁ-S is in recipient of a predoctoral fellowship from the Vall d’Hebron Research Institute (VHIR). |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Immunology;10 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Tirotropina |
dc.subject | Graves, Malaltia de |
dc.subject | Expressió gènica |
dc.subject.mesh | Receptors, Thyrotropin |
dc.subject.mesh | Graves Disease |
dc.subject.mesh | Gene Expression |
dc.title | Regulation of TSHR expression in the thyroid and thymus may contribute to TSHR tolerance failure in graves’ disease patients via two distinct mechanisms |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fimmu.2019.01695 |
dc.subject.decs | receptores de tirotropina |
dc.subject.decs | enfermedad de Graves |
dc.subject.decs | expresión génica |
dc.relation.publishversion | https://www.frontiersin.org/articles/10.3389/fimmu.2019.01695/full |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Marín-Sánchez A, Colobran R, Pujol-Borrell R] Immunologia, FOCIS Center of Excellence (FCE), Hospital Universitari Vall d'Hebron, Barcelona, Spain. Recerca en Immunologia Diagnòstica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Biologia Cel•lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Barcelona, Spain. [Álvarez-Sierra D] Recerca en Immunologia Diagnòstica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Biologia Cel•lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Barcelona, Spain. [González O] Servei de Cirurgia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Lucas-Martin A] Endocrinology Division, Hospital Universitari Germans Trias Pujol, Badalona, Spain. [Sellés-Sánchez A] Recerca en Immunologia Diagnòstica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Rudilla F] Laboratori d’Immunogenètica I Histocompatibilitat, Banc de Sang i Teixits, Grup de recerca en Medicina Transfusional, Hematologia i Hematoteràpia, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 31379878 |
dc.identifier.wos | 000475915400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |